chartexchange

TRDA
Entrada Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:54 PM EST
5.04USD+1.613%(+0.08)815,429
After-hoursNov 18, 2026 4:00:30 PM EST
5.03USD-0.198%(-0.01)

TRDA Financials

In Q3 FY 2026 (ended ), Entrada Therapeutics, Inc. Common Stock (TRDA) reported revenue of $905K, net income of −$39.74M, operating cash flow of −$29.96M, and assets of $266.88M (filed ).

Loading financial statements…